Australian Broker Call

Macquarie rates 29M as No Rating (-1) -

Macquarie resumes coverage of 29Metals with a 30c target, down from 46c, and an Outperform rating following the lifting of a research restriction.

The broker suggests funding concerns have largely been resolved after an equity raise, leaving $33m of cash on the balance sheet.

Refinanced debt and a revised repayment profile will reduce repayments by -US$74m over the next two years, highlights the analyst.

Macquarie also expects the Gossan Valley deposit to drive organic growth at Golden Grove, supporting the company's long-term outlook.

Target price is $0.30 Current Price is $0.22 Difference: $0.08
If 29M meets the Macquarie target it will return approximately 36% (excluding dividends, fees and charges).

Current consensus price target is $0.29, suggesting upside of 30.3% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY24:

Forecast for FY25:

Market Sentiment: -0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Bell Potter rates AEL as Hold (3) -

Management at Amplitude Energy has maintained FY25 production guidance, highlights Bell Potter, following a 2Q operational update showing production remained strong and only marginally weaker than the prior quarter.

Average realised gas prices increased to $9.98/GJ from $9.41/GJ in the prior quarter, supported by increased spot sales, note the analysts.

Bell Potter rates the stock as Hold. The target falls to 22c from 23c.

Target price is $0.22 Current Price is $0.20 Difference: $0.02
If AEL meets the Bell Potter target it will return approximately 10% (excluding dividends, fees and charges).

Current consensus price target is $0.26, suggesting upside of 31.3% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Ord Minnett rates ANN as Hold (3) -

Incorporating the latest factory data, raw material prices, and forex changes, Ord Minnett has revised earnings forecasts for Ansell.

The impact is relatively "minor," the analyst states.

Near-term growth is expected to come from the PPE acquisition completed in July. A more robust contribution is anticipated in FY26, driven by cost efficiencies and savings.

Target price rises to $31.60 from $28.50. No change to Hold rating.

Target price is $31.60 Current Price is $34.40 Difference: minus $2.8 (current price is over target).
If ANN meets the Ord Minnett target it will return approximately minus 8% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $30.80, suggesting downside of -8.8% (ex-dividends)

Forecast for FY25:

Forecast for FY26:

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Shaw and Partners rates AVL as Buy (1) -

With Trump 2.0, Shaw and Partners reiterates a positive stance on the demand for critical miners, given the likelihood of increased trade restrictions.

Globally, demand for battery capacity continues to grow, the broker details, supporting Australian Vanadium. The company is building large-scale storage for clean energy.

Shaw retains a Buy, High-Risk rating with a target price of 8c.

Target price is $0.08 Current Price is $0.02 Difference: $0.065
If AVL meets the Shaw and Partners target it will return approximately 433% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY24:

Forecast for FY25:

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Morgans rates BHP as Add (1) -

Morgans saw BHP Group releasing a strong Q2 operating performance with multiple assets producing at the upper end of guidance. Copper South Australia is the only one for which guidance has been lowered.

Jansen Stage 1 remains on schedule and on budget, the broker notes. Management's guidance for net debt between US$11.5-12.5bn proved higher than the broker's US$10.8bn estimate.

Target price has increased to $49.10 from $47.90 despite lowered forecasts. Add.

Target price is $49.10 Current Price is $39.80 Difference: $9.3
If BHP meets the Morgans target it will return approximately 23% (excluding dividends, fees and charges).

Current consensus price target is $45.10, suggesting upside of 15.5% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.8

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Shaw and Partners rates BML as Buy (1) -

Boab Metals' December quarter update showed a cash balance of $3.5m at the end of 2024, notes Shaw and Partners.

The broker highlights silver as one of its preferred commodities for 2025 and emphasises the company's Sorby Hills project as one of the most advanced silver developments on the ASX.

Shaw and Partners points to the highlight of the quarter report as the binding off-take agreement with Trafigura, which includes a US$30m prepayment facility.

Management is contemplating the acquisition of the DeGrussa processing plant, potentially lowering the upfront spend on Sorby Hills.

The Buy, High-Risk rating, and 40c target are maintained. 

Target price is $0.40 Current Price is $0.17 Difference: $0.23
If BML meets the Shaw and Partners target it will return approximately 135% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY24:

Forecast for FY25:

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Bell Potter rates BPT as Buy (1) -

Average second-quarter realised prices across all Beach Energy products rose by 7%, with gas up by 3% and LNG cargo offsetting weaker oil prices, explains Bell Potter.

The analysts highlight strong group sales and revenue driven by two LNG swap cargos traded during the second quarter, generating $155m in revenue at prices of $17/mmbtu.

FY25 production guidance of 17.5-21.5mmboe is unchanged and capex remains on target, according the broker.

Bell Potter maintains a Buy rating and raises the target price to $1.65 from $1.50, supported by higher sales volumes and realised prices.

Target price is $1.65 Current Price is $1.48 Difference: $0.17
If BPT meets the Bell Potter target it will return approximately 11% (excluding dividends, fees and charges).

Current consensus price target is $1.56, suggesting upside of 2.5% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

Market Sentiment: 0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Morgan Stanley rates BPT as Underweight (5) -

Morgan Stanley observes 2Q25 sales revenue for Beach Energy rose 32% on the previous quarter and 5% year-on-year, exceeding both the broker's and consensus estimates due to two LNG cargoes lifted under a swap agreement.

Capex was in line with estimates, and management continues to anticipate first gas for Waitsia in the June 2025 quarter, with a ramp-up period of three to four months.

The broker highlights 1H25 earnings on February 6. No change to forecasts.

Target price $1.46. Underweight. Sector call: In-Line.

Target price is $1.46 Current Price is $1.48 Difference: minus $0.02 (current price is over target).
If BPT meets the Morgan Stanley target it will return approximately minus 1% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $1.56, suggesting upside of 2.5% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

Market Sentiment: 0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

UBS rates BPT as Buy (1) -

Beach Energy reported a "strong" 2Q25 activities report, comments UBS. Robust LNG prices, along with an additional two LNG swap sales, helped sales revenue exceed expectations by over 15%.

The analyst notes two more LNG swap sales are expected in the March quarter, which lifts the broker's EPS forecast by 4% in FY25.

One suggestion made is Waitsia's ramp-up remains a concern for investors. UBS assumes first sales in May and nameplate capacity by July 2025. Risks also persist around mixed drilling results in the Perth Basin and the Otway project.

Buy rating retained due to potentially rising cash flows in FY26 from higher realised gas pricing and uncontracted East Coast gas volumes.

Target price revised to $1.55 from $1.60.

Target price is $1.55 Current Price is $1.48 Difference: $0.07
If BPT meets the UBS target it will return approximately 5% (excluding dividends, fees and charges).

Current consensus price target is $1.56, suggesting upside of 2.5% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

Market Sentiment: 0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Citi rates BUB as Neutral (3) -

On first inspection, Citi is upbeat on Bubs Australia's 2Q25 trading update. All regions generated a positive change in momentum, with higher-than-anticipated margins at the group level of 48% versus the broker's 40% forecast from improved packaging.

Operating cash flow came in at $3.9m, compared to outflows in the previous corresponding period, the analyst states. Management reconfirmed FY25 guidance in revenue and break-even earnings before interest and tax.

Citi is encouraged by the report but remains Neutral, High-risk rated. The analyst is seeking further confirmation of sustainable cash flow and clarity on US FDA approval.

Target price is $0.13 Current Price is $0.12 Difference: $0.01
If BUB meets the Citi target it will return approximately 8% (excluding dividends, fees and charges).

Market Sentiment: 0.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Bell Potter rates C79 as Hold (3) -

Chrysos' second-quarter financial and operational update shows three additional Chrysos PhotonAssay units were installed during the period, with revenue of $15.3m in line with Bell Potter's forecast.

One unit is currently being deployed, and the analysts project six more units will be deployed in the second half of FY25, bringing the total to 11 for the year, supporting the reiterated FY25 revenue and earnings (EBITDA) guidance.

Bell Potter retains a Hold rating and raises the target price to $5.70 from $5.50.

Target price is $5.70 Current Price is $5.21 Difference: $0.49
If C79 meets the Bell Potter target it will return approximately 9% (excluding dividends, fees and charges).

Current consensus price target is $6.37, suggesting upside of 22.4% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Ord Minnett rates C79 as Accumulate (2) -

Ord Minnett notes the 2Q25 update from Chrysos broadly met expectations, with 24 deployed units in line with assumptions and revenue slightly exceeding expectations due to record sample volumes.

The broker highlights that two leases were signed during the period, and the company is engaged with 70% of the world's 15 largest gold miners, of which seven employ PhotonAssay, the analyst explains.

The target price is raised to $6.40 from $6.09, with no change to the Accumulate rating.

Target price is $6.40 Current Price is $5.21 Difference: $1.19
If C79 meets the Ord Minnett target it will return approximately 23% (excluding dividends, fees and charges).

Current consensus price target is $6.37, suggesting upside of 22.4% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Shaw and Partners rates C79 as Buy (1) -

Chrysos announced its 2Q25 activities and business update with the company deploying plus-three units and contracting plus-two units, Shaw and Partners notes. The strategy to target miners directly is seemingly working, the analyst notes.

Year to date the company has contracted plus-six units compared to plus-one unit in FY24.

Management reconfirmed FY25 guidance with 1H25 revenue growth of 52% on the previous corresponding period trending at the upper end of guidance range.

The analyst lowers EPS forecasts with a higher capex assumption for FY25 of around -$20m. Shaw and Partners reiterates its Buy rating (High Risk). Target price falls to $7 from $7.20.

Target price is $7.00 Current Price is $5.21 Difference: $1.79
If C79 meets the Shaw and Partners target it will return approximately 34% (excluding dividends, fees and charges).

Current consensus price target is $6.37, suggesting upside of 22.4% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

UBS rates CNU as Neutral (3) -

UBS observes the 2Q25 trading update from Chorus. The company lost -10k lines over the period, which met expectations at -9k, although on an annualised basis, the loss is marginally "worse," the analyst notes.

Total line loss in 1H25 came in at -20k, or -40k annualised, well above UBS's forecast of -29k for FY25. 2H25 may prove to be more robust, with students returning to university and new premise connections being constructed with fibre, the broker states.

UBS notes the uptake of the home fibre product might be generating some switching from the older product and some trading down, as total fibre connections advanced over 6k.

Chorus is due to report its 1H25 earnings result on February 24. No change to EPS forecasts.

Neutral retained. Target price unchanged at NZ$8.50.

Current Price is $7.87. Target price not assessed.

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Macquarie rates CSC as Outperform (1) -

Unplanned maintenance at the Pinto Valley operations in Arizona impacted fourth-quarter production for Capstone Copper, observes Macquarie.

Copper production for the period missed the consensus forecast by -8%, while C1 cash costs were also -8% worse-than-expected.

The broker highlights initial FY25 guidance for copper production of 220-255kt was -5% below consensus, with cash cost guidance of US$2.20-2.50/lb representing a -4% miss.

Macquarie maintains an Outperform rating but lowers the target price to $11.50 from $12.00.

Target price is $11.50 Current Price is $9.70 Difference: $1.8
If CSC meets the Macquarie target it will return approximately 19% (excluding dividends, fees and charges).

Current consensus price target is $12.67, suggesting upside of 35.9% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY24:

Forecast for FY25:

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Ord Minnett rates CVN as Downgrade to Hold from Buy (3) -

Ord Minnett downgrades Carnarvon Energy to Hold from Buy, with a lower target price of 14c from 21c due to uncertainty surrounding the delay in the start of the Dorado oil and gas project by Santos ((STO)).

A final investment decision is not expected until 2028, the analyst states.

Dorado is a key asset for Carnarvon, and the broker highlights questions around how much the company can achieve for its stake given the uncertainty regarding the development timeframe.

Target price is $0.14 Current Price is $0.12 Difference: $0.025
If CVN meets the Ord Minnett target it will return approximately 22% (excluding dividends, fees and charges).

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Bell Potter rates CXL as Downgrade to Speculative Hold from Speculative Buy (3) -

Bell Potter lowers its target price for Calix to 80c from $1.55 and downgrades its rating to Speculative Hold from Speculative Buy after reviewing its investment thesis.

The analysts attribute these changes to uncertainty surrounding US policies promoting decarbonisation and the company's Heirloom-Leilac partnership.

The Trump Administration has issued an Executive Order advising federal agencies to pause distributing funds under the Inflation Reduction Act and halt leasing and permitting of renewable energy projects.

The process to withdraw the US from the Paris Agreement has also been restarted, and reports suggest Trump may propose rescinding the Inflation Reduction Act entirely, notes the broker.

Target price is $0.80 Current Price is $0.72 Difference: $0.08
If CXL meets the Bell Potter target it will return approximately 11% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Citi rates EVN as Downgrade to Neutral from Buy (3) -

Citi raises its target price for Evolution Mining to $5.80 from $5.50 and downgrades its rating to Neutral from Buy on valuation, after further analysis of yesterday's 2Q operational report.

A summary of yesterday's research by Citi follows.

Citi's first impression of Evolution Mining's 2Q25 report suggests a likely positive market response.

Production and costs were better to in line with consensus, while higher commodity prices drove record cash flow.

The analyst highlights cash flow as a standout, boosting cash on hand by 36% over the prior quarter to $520m.

Citi notes growth in capex exceeded expectations due to the pull-forward of -$80m in Mungari capex to FY25 from FY26.

Target price is $5.80 Current Price is $5.89 Difference: minus $0.09 (current price is over target).
If EVN meets the Citi target it will return approximately minus 2% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $5.40, suggesting downside of -4.8% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

Market Sentiment: -0.2

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Macquarie rates EVN as Downgrade to Underperform from Neutral (5) -

Macquarie believes Evolution Mining is on track to meet FY25 guidance for production and costs (AISC) following a review of second-quarter operational results.

The analyst highlights the Cowal mine as a key 2Q contributor, with production increasing by 10% quarter-on-quarter.

The broker raises its target price to $5.50 from $5.20 and downgrades the rating to Underperform from Neutral, reflecting the recent share price rise.

Target price is $5.50 Current Price is $5.89 Difference: minus $0.39 (current price is over target).
If EVN meets the Macquarie target it will return approximately minus 7% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $5.40, suggesting downside of -4.8% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

Market Sentiment: -0.2

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Ord Minnett rates EVN as Hold (3) -

Ord Minnett notes Evolution Mining announced a "strong" 2Q25 report, with both production and all-in-sustaining costs meeting expectations.

Management lowered gearing by -1%, the analyst observes, despite higher-than-anticipated capex of over -$58m.

FY25 production guidance remains unchanged, and the mill expansion at Mungari has been brought forward, with capex of around -$105m.

The analyst expects commissioning in 4Q25, with the feasibility study on the Ernest Henry Mine expansion due for completion in 3Q25.

No change to the Hold rating. The target price rises to $5.35 from $5.10.

Target price is $5.35 Current Price is $5.89 Difference: minus $0.54 (current price is over target).
If EVN meets the Ord Minnett target it will return approximately minus 9% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $5.40, suggesting downside of -4.8% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

Market Sentiment: -0.2

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

UBS rates EVN as Neutral (3) -

Evolution Mining reported 2Q25 gold production of 194.8koz, which met both consensus and UBS estimates.

The March quarter is expected to be weak due to the 28-day shutdown at Cowal, the broker explains, but even with this softness, the company remains on track for FY26 guidance.

Copper production also met expectations at 18.6kt, and all-in-sustaining costs were broadly in line. Group cash flow was $165m, with net debt at $1.23bn after a $99m dividend payout, the analyst stated.

UBS notes the Mungari expansion is tracking ahead of expectations and under budget, with commissioning brought forward by nine months.

The broker's FY25 EPS forecast slips by -3%, while FY26 EPS is raised by 6%.

Neutral rating and $5.40 target are unchanged.

Target price is $5.40 Current Price is $5.89 Difference: minus $0.49 (current price is over target).
If EVN meets the UBS target it will return approximately minus 8% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $5.40, suggesting downside of -4.8% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

Market Sentiment: -0.2

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Citi rates FMG as Neutral (3) -

In a first look at today's 2Q production report released by Fortescue, Citi highlights iron ore shipments of 49.4mt now take 1H shipments to 97.1mt, the highest ever.

Hematite shipments of 47.9mt matched the broker's estimate, while Iron Bridge shipments of 1.5mt exceeded expectations.

Hematite average revenue of US$87.40/dmt reflected an 85% realisation to the Platts 62% index, slightly below the analysts' 86% forecast.

A beat in hematite cash costs was due to increased ore mining volumes, a lower strip ratio, and favourable currency movements, explains Citi.

The Neutral rating and $21 target price are maintained.

Target price is $21.00 Current Price is $19.03 Difference: $1.97
If FMG meets the Citi target it will return approximately 10% (excluding dividends, fees and charges).

Current consensus price target is $18.72, suggesting upside of 0.8% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: -0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Morgan Stanley rates GDG as Overweight (1) -

Morgan Stanley retains a "keep" Overweight rating on Generation Development following the 2Q25 report, which showed a 31% year-on-year increase in total FUM, 2.5% ahead of the broker's forecast.

Net inflows rose by 112%, with gross inflows up 61% compared to the previous corresponding period.

The analyst describes the 2Q25 performance as "strong," highlighting a record performance from General Life Investment Bonds for gross inflows. Momentum at Lonsec was also maintained.

Overweight. Target price: $4.75. Industry View: In-Line.

Target price is $4.75 Current Price is $4.27 Difference: $0.48
If GDG meets the Morgan Stanley target it will return approximately 11% (excluding dividends, fees and charges).

Current consensus price target is $4.67, suggesting upside of 9.3% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Morgans rates GDG as Upgrade to Add from Hold (1) -

Morgans has upgraded Generation Development to Add from Hold with an increased price target to $4.75 from $4.01 following a "very strong" Q2 update, which included record investment bond sales of $250m.

The latter represents the third consecutive record quarter for the company, the broker highlights.

Morgans says Generation Development is a great story and management has executed well. The broker has upgraded forecasts, but also longer-term growth assumptions.

Target price is $4.75 Current Price is $4.27 Difference: $0.48
If GDG meets the Morgans target it will return approximately 11% (excluding dividends, fees and charges).

Current consensus price target is $4.67, suggesting upside of 9.3% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Ord Minnett rates GDG as Buy (1) -

Ord Minnett highlights Generation Development reported an "excellent" 2Q25 update, with bond FUM up 7.1% on the previous quarter to $3.84bn, ahead of the broker's forecast.

The analyst believes business momentum remains intact, with investment bond sales exceeding estimates. Lonsec's FUM growth of 8.3% over the period also outperformed the broker's expectations.

Ord Minnett raises EPS forecasts by 2%-6% for FY25-FY27, reflecting higher expectations for bond FUM and Lonsec growth.

Buy rating remains unchanged. Target price increases to $4.50 from $3.90.

Target price is $4.50 Current Price is $4.27 Difference: $0.23
If GDG meets the Ord Minnett target it will return approximately 5% (excluding dividends, fees and charges).

Current consensus price target is $4.67, suggesting upside of 9.3% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Macquarie rates GNC as Outperform (1) -

In a preview of GrainCorp's AGM on February 13, Macquarie expects the release of FY25 guidance ranges. Both the broker and consensus currently forecast FY25 earnings (EBITDA) of $325m.

The Outperform rating and $9.85 target price are maintained. The analyst highlights GrainCorp's attractive dividend yield.

Target price is $9.85 Current Price is $7.31 Difference: $2.54
If GNC meets the Macquarie target it will return approximately 35% (excluding dividends, fees and charges).

Current consensus price target is $9.46, suggesting upside of 30.9% (ex-dividends)

The company's fiscal year ends in September.

Forecast for FY25:

Forecast for FY26:

Market Sentiment: 0.6

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Citi rates ILU as Downgrade to Neutral from Buy (3) -

In a second look at yesterday's 4Q update by Iluka Resources, Citi lowers its target to $5.60 from $6.10 and downgrades to Neutral High Risk from Buy High Risk.

The FNArena summary of yesterday's research by Citi follows.

Citi observes a disappointing December quarter report from Iluka Resources, with mineral sands revenue falling -17% below the analyst's estimate and zircon, rutile, and synthetic rutile volumes down -12%.

Pricing was mixed, with average zircon sand premium and standard prices below Iluka's guidance, down -4.8% on the prior quarter. Citi notes zircon prices declined from 3Q, while rutile and synthetic rutile saw slight increases.

Management plans to remove 130 roles, which Citi estimates will deliver a -$20m cost reduction for 2025.

The company indicated proposed tariffs on Chinese imports to Europe and other regions in 1H25 may benefit Western pigment producers.

Target price is $5.60 Current Price is $4.95 Difference: $0.65
If ILU meets the Citi target it will return approximately 13% (excluding dividends, fees and charges).

Current consensus price target is $6.13, suggesting upside of 32.4% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY24:

Forecast for FY25:

Market Sentiment: 0.4

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Macquarie rates ILU as Outperform (1) -

Iluka Resources delivered strong Q4 production and revenue results, but Macquarie highlights weak 2025 production guidance as a key disappointment, with rutile and synthetic rutile falling -19% and -23% short of consensus forecasts, respectively.

The broker notes that 2025 cash cost guidance also missed consensus by -10%.

Management announced the ongoing curtailment of SR1 operations in 2025, which the analyst suggests reflects an increasingly cautious outlook for the TiO2 feedstock market.

Macquarie maintains an Outperform rating but lowers the target price by -4% to $6.80, reflecting weaker near-term earnings forecasts.

Target price is $6.80 Current Price is $4.95 Difference: $1.85
If ILU meets the Macquarie target it will return approximately 37% (excluding dividends, fees and charges).

Current consensus price target is $6.13, suggesting upside of 32.4% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY24:

Forecast for FY25:

Market Sentiment: 0.4

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Morgan Stanley rates ILU as Equal-weight (3) -

Iluka Resources reported better-than-expected production and sales for 4Q 2024, according to Morgan Stanley, with prices essentially meeting forecasts.

Zircon production lifted 20% and synthetic rutile 16%, both above forecasts, the broker states.

Management lowered 2025 production guidance by -20% as the synthetic rutile kiln restart has been deferred due to weak prices and a soft market. Cash cost guidance also came in higher than expected by 30% compared to the broker and consensus estimates.

Equal-weight rating retained. Target price $5.80. Industry view: Attractive.

Target price is $5.80 Current Price is $4.95 Difference: $0.85
If ILU meets the Morgan Stanley target it will return approximately 17% (excluding dividends, fees and charges).

Current consensus price target is $6.13, suggesting upside of 32.4% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY24:

Forecast for FY25:

Market Sentiment: 0.4

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Ord Minnett rates ILU as Buy (1) -

Ord Minnett describes the 4Q 2024 update from Iluka Resources as "sombre," as soft demand for zircon impacted sales, with the analyst expecting a price decline of around -5% in 1Q 2025 and a similar drop in the synthetic rutile price.

Management has cut 130 staff, including those at synthetic rutile operations, so the broker considers a swift restart of the kiln as unlikely.

The company has guided for higher costs in 2025, partly due to the preparation of Balranald. The target price falls to $5.75 from $6.00. Buy rating unchanged.

Target price is $5.75 Current Price is $4.95 Difference: $0.8
If ILU meets the Ord Minnett target it will return approximately 16% (excluding dividends, fees and charges).

Current consensus price target is $6.13, suggesting upside of 32.4% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY24:

Forecast for FY25:

Market Sentiment: 0.4

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Macquarie rates LOV as Outperform (1) -

Macquarie anticipates continued strong store rollouts by Lovisa Holdings, supported by population growth in North America and Europe.

The broker forecasts a total of 960 Lovisa stores by the end of January, representing an increase of 60 since the FY24 result.

The analyst expects the incoming CEO to be motivated to achieve EBIT growth above 18% to secure incentive payments.

Macquarie maintains an Outperform rating and a $34.10 target price.

Target price is $34.10 Current Price is $28.14 Difference: $5.96
If LOV meets the Macquarie target it will return approximately 21% (excluding dividends, fees and charges).

Current consensus price target is $30.71, suggesting upside of 9.3% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

Market Sentiment: 0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Macquarie rates LTR as Underperform (5) -

Liontown Resources' second-quarter operational results exceeded forecasts by Macquarie and consensus on most metrics, except for recoveries.

The broker remains cautious with an Underweight rating, awaiting improvement in the lithium sector before adopting a more constructive stance.

Macquarie believes commercial production is imminent, with management successfully demonstrating a ramp-up of the processing plant despite challenging market conditions.

The broker maintains its 60c target price.

Target price is $0.60 Current Price is $0.71 Difference: minus $0.105 (current price is over target).
If LTR meets the Macquarie target it will return approximately minus 15% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $0.74, suggesting upside of 12.6% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

Market Sentiment: -0.2

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Ord Minnett rates LTR as Hold (3) -

The ramp-up of Kathleen Valley proceeded ahead of expectations in 2Q25, according to Ord Minnett, leading Liontown Resources to report higher-than-expected spodumene output and shipments.

Realised spodumene concentrate prices met expectations, although unit costs were higher but in line with forecasts, the broker states.

Ord Minnett increases the forecast EPS loss for FY25, while the FY26 estimated EPS moves to breakeven.

The target price rises to 68c from 62c, with the Hold rating maintained

Target price is $0.68 Current Price is $0.71 Difference: minus $0.025 (current price is over target).
If LTR meets the Ord Minnett target it will return approximately minus 4% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $0.74, suggesting upside of 12.6% (ex-dividends)

Forecast for FY25:

Forecast for FY26:

Market Sentiment: -0.2

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Morgans rates NST as Add (1) -

Add rating retained as Morgans believes Northern Star Resources is poised for a stronger second half performance. Q2 production proved in line with guidance, but trending towards the lower end, the broker points out.

It is Morgans' view the pending acquisition of De Grey Mining ((DEG)) re-affirms management's commitment to achieving growth.

Weather and increased waste at KCMG caused Q2 volume to disappoint, but Morgans also points out the $300m share buyback has resumed, with 86% now completed.

Target price falls to $20.04 from $20.18.

Target price is $20.04 Current Price is $17.26 Difference: $2.78
If NST meets the Morgans target it will return approximately 16% (excluding dividends, fees and charges).

Current consensus price target is $18.07, suggesting upside of 4.7% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Citi rates NWL as Upgrade to Neutral from Sell (3) -

Citi's initial assessment of Netwealth Group's second-quarter business update leads to an increase in the broker's earnings (EBITDA) forecasts by 2% to 6%, driven by stronger funds under administration (FUA) growth and an improved revenue margin.

Netwealth's custodial FUA of $101bn marked a 30% year-on-year increase and exceeded the broker's forecast by 3%, supported by stronger flows and positive market movements.

Citi raises its target price to $30.70 from $28.90 and upgrades the rating to Neutral from Sell.

Target price is $30.70 Current Price is $29.41 Difference: $1.29
If NWL meets the Citi target it will return approximately 4% (excluding dividends, fees and charges).

Current consensus price target is $27.29, suggesting downside of -9.4% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

Market Sentiment: 0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Citi rates NXT as Buy (1) -

Following the US Government's announcement of additional chip restrictions, ranking countries across three tiers of restriction, Citi does not expect a materially negative impact on NextDC.

The company's Asian data centre plans, accounting for only around 8% of the broker's FY30 EBITDA forecast, may face challenges.

The analyst notes Asian operations could be affected by a new cap of 50,000 chips for Tier 2 countries (e.g. Malaysia) and the limitation of US data centre companies to no more than 7% of their computing power in any single non-US ally country.

The broker retains a Buy rating and a $20 target price.

Target price is $20.00 Current Price is $16.09 Difference: $3.91
If NXT meets the Citi target it will return approximately 24% (excluding dividends, fees and charges).

Current consensus price target is $20.12, suggesting upside of 25.3% (ex-dividends)

Forecast for FY25:

Forecast for FY26:

Market Sentiment: 0.9

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Bell Potter rates PDN as Buy (1) -

Paladin Energy's 2Q production of 640klbs exceeded Bell Potter's forecast of 540klbs, while C1 costs of US$42.3/lb were below the broker's estimate of US$51/lb.

An uptick in recoveries to 88% (compared to the forecast of 70%) highlighted an improved plant performance, observes the analyst.

Management expects to achieve the low end of FY25 production guidance.

Stabilisation of water availability during the period reduces the risk of intermittent shutdowns in the second half, although persistently lower feed grades may challenge efforts to increase production, suggests Bell Potter.

The broker retains a Buy rating and raises the target price to $10.70 from $10.50, reflecting updated production forecasts.

Target price is $10.70 Current Price is $9.19 Difference: $1.51
If PDN meets the Bell Potter target it will return approximately 16% (excluding dividends, fees and charges).

Current consensus price target is $11.56, suggesting upside of 25.6% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.8

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Morgan Stanley rates PDN as Overweight (1) -

Morgan Stanley notes a "pleasingly" better production report for Paladin Energy's Langer Heinrich in 2Q25, with plant recovery improving to 88% following the November works, exceeding expectations.

There were no water disruptions, with NamWater deliveries improving over the period. Grades were below expectations and remain variable, the analyst states.

Paladin has cash on hand of US$117m, excluding restricted cash. Target price remains unchanged at $10.25. Overweight. Industry view: Attractive.

There are no changes to the analyst's earnings forecasts.

Target price is $10.25 Current Price is $9.19 Difference: $1.06
If PDN meets the Morgan Stanley target it will return approximately 12% (excluding dividends, fees and charges).

Current consensus price target is $11.56, suggesting upside of 25.6% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.8

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Shaw and Partners rates PDN as Buy (1) -

Shaw and Partners observes Paladin Energy reported a "much-improved" 2Q25 report following the September quarter commissioning problems.

Production at Langer Heinrich reached 638klb of U3O8, with 309klb produced in 2Q after the shutdown in November.

The analyst highlights Paladin is on track to meet management's updated guidance of 3-3.6mlb in FY25, and the plant has achieved 88% recovery in the latest quarter, up from 69% in the previous quarter.

Shaw and Partners retains Paladin as the preferred uranium stock with a Buy, High-Risk rating and $15.80 target price.

The market tends to track the U3O8 spot price, but the analyst believes a better indicator of industry fundamentals is the contracting price, which stands above US$100/lb.

Target price is $15.80 Current Price is $9.19 Difference: $6.61
If PDN meets the Shaw and Partners target it will return approximately 72% (excluding dividends, fees and charges).

Current consensus price target is $11.56, suggesting upside of 25.6% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.8

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

UBS rates PDN as Buy (1) -

UBS downgrades Paladin Energy to Neutral from Buy, with a rise in the target price to $10 from $9.90. The company is viewed as fully priced following the December quarter trading update.

The broker observes the water problems have been resolved, and nameplate capacity for Langer Heinrich is anticipated by FY25 end.

Management retained guidance of 3-3.6mlbs, with 0.3mlb produced in 2Q25, or around 3.6mlbs annualised, the broker notes.

Sales fell circa -20% on the previous quarter. The company attributes this to delayed shipping into January, and the lower realised price of -6% was also due to the delayed shipment.

With the completion of the Fission acquisition, UBS highlights free cash flow of around US$410m in 1H25, which should moderate concerns around debt and cash flow generation.

Neutral rated. Target $10.

Target price is $10.00 Current Price is $9.19 Difference: $0.81
If PDN meets the UBS target it will return approximately 9% (excluding dividends, fees and charges).

Current consensus price target is $11.56, suggesting upside of 25.6% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.8

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Ord Minnett rates PNR as Speculative Buy (1) -

Pantoro reported a mixed 2Q25 activities report, with Ord Minnett highlighting a higher proportion of lower-grade stockpiles offsetting higher-grade underground supply, resulting in a quarter-on-quarter production decline of -9%.

Management lowered FY25 guidance by -10% due to delays in material from the Scotia underground. The broker believes the market was already anticipating this downgrade.

The target price decreases to 15c from 16c. Speculative Buy rating remains unchanged.

Target price is $0.15 Current Price is $0.10 Difference: $0.05
If PNR meets the Ord Minnett target it will return approximately 50% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Citi rates RIO as Neutral (3) -

While talks are not currently active (despite recent media reports), Citi points out the real prize of a merger between Rio Tinto and Glencore would be to lift the combined entity to the top-3 copper businesses globally.

The analysts suggest a potential limiting factor for Rio could be Glencore's coal business, given Rio’s recent exit from coal operations.

Citi maintains its $134 target and Neutral rating for Rio Tinto.

Target price is $134.00 Current Price is $119.61 Difference: $14.39
If RIO meets the Citi target it will return approximately 12% (excluding dividends, fees and charges).

Current consensus price target is $129.17, suggesting upside of 9.5% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY24:

Forecast for FY25:

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

UBS rates RMD as Neutral (3) -

ResMed is due to report its 2Q25 activities report on January 31, with UBS noting the analyst's topline forecast aligns with consensus, alongside a gross margin estimate of 59.9%, a rise of 20bps from the previous quarter.

The broker believes the company receives "too little credit" for cost control operationally.

With the FDA approval of Eli Lilly's Zepbound GLP-1 treatment for sleep apnoea, ResMed is not expecting a significant upward push in sales but holds a belief, based on IQVIA data, that PAP therapy will be used alongside GLP-1 treatments.

The stock remains Neutral rated. Target price rises to US$255 from US$250.

Current Price is $39.50. Target price not assessed.

Current consensus price target is $41.08, suggesting upside of 4.6% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Forecast for FY26:

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.6

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Citi rates STO as Buy (1) -

Fourth quarter production for Santos was in line, while revenue beat Citi's forecast on timing of cargoes, explains the broker in a first take on today's operational update.

Production guidance for 2025 of between 90-97mmboe convincingly beat the analysts' expectations, possibly due to the Angore wells coming online at PNG LNG.

More negatively, free cash flow (FCF) from operations missed the broker's forecast and 2025 capex guidance suggests capital intensity of the base business is higher-than-anticipated.

Target $7.60. Buy.

Target price is $7.60 Current Price is $7.13 Difference: $0.47
If STO meets the Citi target it will return approximately 7% (excluding dividends, fees and charges).

Current consensus price target is $8.02, suggesting upside of 12.6% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY24:

Forecast for FY25:

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Ord Minnett rates VMM as Upgrade to Buy from Hold (1) -

Ord Minnett upgrades Viridis Mining and Minerals to Buy from Hold, retaining a $1 target price.

The company updated the mineral resource estimate for Colossus to 93mt, a rise of 140%, giving the company 106mt of high-grade total rare earth oxides.

The analyst upgrades the NAV on Colossus by 34c to $2.95 per share, noting the stock trades at a sizeable discount to Meteoric Resources ((MEI)) despite possessing a similar asset.

Ord Minnett also highlights considerable hurdles for production, as demand for mixed rare earth carbonates remains "thin." A strategic partner or a rebound in sentiment is needed to develop Colossus, the broker explains.

Target price is $1.00 Current Price is $0.43 Difference: $0.57
If VMM meets the Ord Minnett target it will return approximately 133% (excluding dividends, fees and charges).

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Macquarie rates WAF as Outperform (1) -

Macquarie highlights a positive cost (AISC) performance for the fourth quarter by West African Resources, beating the broker's forecast by 12%, following pre-reported production results last week.

Capital spending at Kiaka totaled -$160m, exceeding the broker's forecast by -$42m, driven by ongoing project investment. Management remains on track to deliver first gold at Kiaka by the third quarter of 2025, with -US$135m of growth capex remaining.

Macquarie maintains its $2.20 target price and Outperform rating.

Target price is $2.20 Current Price is $1.67 Difference: $0.53
If WAF meets the Macquarie target it will return approximately 32% (excluding dividends, fees and charges).

The company's fiscal year ends in December.

Forecast for FY24:

Forecast for FY25:

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Citi rates WDS as Sell (5) -

After further analysis of Woodside Energy's 4Q operational update, Citi lowers its target to $23.00 from $23.50 and maintains a Sell rating.

Summary of yesterday's research by Citi.

Citi's first take on Woodside Energy's 4Q24 report suggests slightly "softer" activities and outlook.

The analyst notes headline numbers met expectations and consensus estimates, but further inspection reveals underlying weakness. LNG pricing was softer, though offset by higher LNG trading revenue, which was in line.

Pricing at North West Shelf, Bass Strait, and Trinidad & Tobago was weaker than anticipated.

Management provided no updates on Scarborough or Louisiana LNG.

Woodside is set to report 2024 results on 14 February. 

Target price is $23.00 Current Price is $25.25 Difference: minus $2.25 (current price is over target).
If WDS meets the Citi target it will return approximately minus 9% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $27.23, suggesting upside of 9.0% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY24:

Forecast for FY25:

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Morgan Stanley rates WDS as Equal-weight (3) -

Woodside Energy reported 4Q 2024 production, meeting Morgan Stanley's forecast and beating consensus by 2%, driven by robust LNG availability and Sangomar production, the broker states.

Revenue for the quarter came in lower than expected, with 33.6% of LNG sold at a 31% premium to oil-linked pricing, the analyst explains. Capex met expectations.

Management highlighted Scarborough as 78% complete, with first production targeted for 2026. Woodside Energy is set to report 2024 earnings on February 25.

Equal-weight rating and $27 target remain unchanged. Sector call: In-Line.

Target price is $27.00 Current Price is $25.25 Difference: $1.75
If WDS meets the Morgan Stanley target it will return approximately 7% (excluding dividends, fees and charges).

Current consensus price target is $27.23, suggesting upside of 9.0% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY24:

Forecast for FY25:

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Ord Minnett rates WDS as Hold (3) -

Ord Minnett notes Woodside Energy reported December quarter production and revenue that met both the analyst's and consensus expectations.

Cost guidance for 2025 has been raised in relation to Scarborough, raising some concerns about whether the project remains on budget. Ord Minnett is "comfortable" with the change and believes the project is still under budget.

The broker increases the 2024 EPS estimate by 2% and the 2025 forecast by 1%.

No change to the Hold rating. The target price decreases to $26 from $26.50.

Target price is $26.00 Current Price is $25.25 Difference: $0.75
If WDS meets the Ord Minnett target it will return approximately 3% (excluding dividends, fees and charges).

Current consensus price target is $27.23, suggesting upside of 9.0% (ex-dividends)

Forecast for FY24:

Forecast for FY25:

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

UBS rates WDS as Neutral (3) -

UBS notes Woodside Energy reported a "strong" 4Q 2024. Sales came in above consensus by 9% and exceeded UBS's estimate by 2%, driven by more robust marketing and trading revenues and higher realised pricing.

The analyst highlights better production at the new Sangomar oil project as the "highlight," though overall production was softer than anticipated due to declines in the Gulf of Mexico, Shenzi, and Atlantis, along with mixed performance at LNG Pluto and Wheatstone.

UBS expects management to update guidance in the forthcoming 2024 earnings results. The analyst notes the December asset swap pricing is currently not reflected in consensus estimates.

The analyst raises the 2024 EPS forecast by 3% and lowers the 2025 EPS forecast by -4%.

Neutral rating and $27.40 target are retained.

Target price is $27.40 Current Price is $25.25 Difference: $2.15
If WDS meets the UBS target it will return approximately 9% (excluding dividends, fees and charges).

Current consensus price target is $27.23, suggesting upside of 9.0% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY24:

Forecast for FY25:

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources